Early Episode Psychosis
Early-episode psychosis is a prime time for medical intervention, which may include multimodal therapies, case management, and a focus on self-determination. Treatment focuses on enabling individuals to move on from the acute impact of a psychotic episode and chart the course of their own recovery. In this Early Episode Psychosis Topic Library, find resources about treatment interventions and other information.
Featured Resources
ADHD Interview With Dr. Newcorn: Part 1
-
Getting Social Determinants Of Health Services Covered Under Medicaid & Chip
Downloadable ResourceOctober 29, 2021There are many resources available under Medicaid and the Children’s Health Insurance Program (CHIP) that can help providers address SDOH…. -
The 12 Steps To Inclusivity In Mental Health Services (Part IV)
InterviewOctober 25, 2021From the 2019 Pew Research Center survey of over 25 countries on people's view of diversity in their country, most… -
Decriminalizing Mental Illness
InterviewSeptember 30, 2021U.S. correctional institutions, local courts, and police officers frequently encounter people with untreated mental health disorders. Once incarcerated, individuals with…
First Episode Psychosis: Focus On US Hispanic Population
-
Viruses, Vaccines, & Long-Term Consequences: Panel Perspectives
InterviewNovember 16, 2021 -
PsychU Suicide Prevention Brochure
Downloadable ResourceNovember 15, 2021 -
ADHD Interview With Dr. Newcorn: Part 2
InterviewNovember 9, 2021
Early Episode Psychosis Resources
Ask A Question About Early Episode Psychosis
Enter your question in the box below and click “Ask My Question” to submit your inquiry.
You must be logged in to ask a question in this section.
Disclaimer: The information provided by PsychU is intended for your educational benefit only. It is not intended as, nor is it a substitute for medical care or advice or professional diagnosis. Treatment-related questions will not be addressed. Users seeking medical advice should consult with their physician or other healthcare professional.
Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) operates in a highly regulated and scrutinized industry. Therefore, we may not be able to address every questions or topic submitted. Topics which may not be addressed may include, but are not limited to questions related to: (1) specific medications, (2) branded items, (3) clinical or treatment advice relating to specific patient conditions. The lack of response to certain questions or comments should not be taken as an agreement with the view posed or an admission of any kind.
REQUEST A PRESENTATION
Request a free educational program for your organization or region today! These customizable PsychU presentations are available both online and in-person, and cover a range of topics including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and more.
Top Requested Presentations
The Neuropsychiatric Inventory: Development & Applications
Diagnostic & Statistical Manual Of Mental Disorders–Fifth Edition (DSM-5): Key Updates VS DSM-IV-TR
Distinguishing Sedation From Efficacy In Antipsychotic Treatment
Learning Tracks
Not sure where to start on the thousands of resources in the PsychU library? PsychU has created learning tracks to give community members a resource guide! Pick a learning track, review the materials outlined, and complete the Test Your Knowledge questions to participate in a resource ‘crash-course’ on one of the topics listed below.